Detalhe da pesquisa
1.
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry.
J Headache Pain
; 24(1): 157, 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993795